Phlegmon laboratory findings

Jump to: navigation, search

Phlegmon Microchapters

Home

Patient Information

Overview

Classification

Pathophysiology

Causes

Differentiating Phlegmon from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Phlegmon laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Phlegmon laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA onPhlegmon laboratory findings

CDC on Phlegmon laboratory findings

Phlegmon laboratory findings in the news

Blogs on Phlegmon laboratory findings

Directions to Hospitals Treating Phlegmon

Risk calculators and risk factors for Phlegmon laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Overview

On a blood test, leucocytosis (up to 10-12x109/L), decrease or absence of eosinophils, shift of leucocyte formula to the left, and an increased ESR (up to 35-40 mm/hr) may be present. Presence of bacteria in the urine and increased urinary leucocyte counts may be observed on urinalysis.

References



Linked-in.jpg